Tissue-engineering firm Ortec raises $2 million
This article was originally published in Clinica
Executive Summary
Ortec International, a tissue engineering specialist based in New York, has raised $2m from a private placement of convertible preferred stock. The financing round was led by existing investors, and follows an $8.5m fundraising last November.